Nanoemulsions as Effective Carriers for the treatment of Lung Cancer

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Nanotechnology-based Targeted Drug Delivery Systems for Lung Cancer is an indispensable resource that will help pharmaceutical scientists and clinical researchers design and develop novel drug delivery systems and devices for the treatment of lung cancer. As recent breakthroughs in nanomedicine are now making it possible to deliver drugs, genes and therapeutic agents to localized areas of disease to maximize clinical benefit, while also limiting unwanted side effects, this book explores promising approaches for the diagnosis and treatment of lung cancer using cutting-edge nanomedical technologies. Topics discussed include polymeric nanoparticles, solid lipid nanoparticles, liposomes, dendrimers, micelles and nanoemulsions.
LanguageEnglish
Title of host publicationNanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer
EditorsPrashant Kesharwani
PublisherElsevier
Chapter9
Pages217
Number of pages234
Edition1
ISBN (Electronic)9780128163672
ISBN (Print)9780128157206
Publication statusPublished - 31 Jan 2019

Fingerprint

Lung Neoplasms
Drug Delivery Systems
Nanoparticles
Nanomedicine
Dendrimers
Nanotechnology
Micelles
Liposomes
Pharmaceutical Preparations
Therapeutics
Research Personnel
Technology
Lipids
Equipment and Supplies
Genes

Cite this

Tambuwala, M. M. (2019). Nanoemulsions as Effective Carriers for the treatment of Lung Cancer. In P. Kesharwani (Ed.), Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer (1 ed., pp. 217). Elsevier.
Tambuwala, Murtaza M. / Nanoemulsions as Effective Carriers for the treatment of Lung Cancer. Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer. editor / Prashant Kesharwani. 1. ed. Elsevier, 2019. pp. 217
@inbook{e7339b7c3cd54e2eb1485436a473436d,
title = "Nanoemulsions as Effective Carriers for the treatment of Lung Cancer",
abstract = "Nanotechnology-based Targeted Drug Delivery Systems for Lung Cancer is an indispensable resource that will help pharmaceutical scientists and clinical researchers design and develop novel drug delivery systems and devices for the treatment of lung cancer. As recent breakthroughs in nanomedicine are now making it possible to deliver drugs, genes and therapeutic agents to localized areas of disease to maximize clinical benefit, while also limiting unwanted side effects, this book explores promising approaches for the diagnosis and treatment of lung cancer using cutting-edge nanomedical technologies. Topics discussed include polymeric nanoparticles, solid lipid nanoparticles, liposomes, dendrimers, micelles and nanoemulsions.",
author = "Tambuwala, {Murtaza M}",
year = "2019",
month = "1",
day = "31",
language = "English",
isbn = "9780128157206",
pages = "217",
editor = "Kesharwani, {Prashant }",
booktitle = "Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer",
publisher = "Elsevier",
address = "Netherlands",
edition = "1",

}

Tambuwala, MM 2019, Nanoemulsions as Effective Carriers for the treatment of Lung Cancer. in P Kesharwani (ed.), Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer. 1 edn, Elsevier, pp. 217.

Nanoemulsions as Effective Carriers for the treatment of Lung Cancer. / Tambuwala, Murtaza M.

Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer. ed. / Prashant Kesharwani. 1. ed. Elsevier, 2019. p. 217.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Nanoemulsions as Effective Carriers for the treatment of Lung Cancer

AU - Tambuwala, Murtaza M

PY - 2019/1/31

Y1 - 2019/1/31

N2 - Nanotechnology-based Targeted Drug Delivery Systems for Lung Cancer is an indispensable resource that will help pharmaceutical scientists and clinical researchers design and develop novel drug delivery systems and devices for the treatment of lung cancer. As recent breakthroughs in nanomedicine are now making it possible to deliver drugs, genes and therapeutic agents to localized areas of disease to maximize clinical benefit, while also limiting unwanted side effects, this book explores promising approaches for the diagnosis and treatment of lung cancer using cutting-edge nanomedical technologies. Topics discussed include polymeric nanoparticles, solid lipid nanoparticles, liposomes, dendrimers, micelles and nanoemulsions.

AB - Nanotechnology-based Targeted Drug Delivery Systems for Lung Cancer is an indispensable resource that will help pharmaceutical scientists and clinical researchers design and develop novel drug delivery systems and devices for the treatment of lung cancer. As recent breakthroughs in nanomedicine are now making it possible to deliver drugs, genes and therapeutic agents to localized areas of disease to maximize clinical benefit, while also limiting unwanted side effects, this book explores promising approaches for the diagnosis and treatment of lung cancer using cutting-edge nanomedical technologies. Topics discussed include polymeric nanoparticles, solid lipid nanoparticles, liposomes, dendrimers, micelles and nanoemulsions.

UR - https://books.google.co.uk/books?id=yE2FDwAAQBAJ&printsec=frontcover#v=onepage&q&f=false

M3 - Chapter

SN - 9780128157206

SP - 217

BT - Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer

A2 - Kesharwani, Prashant

PB - Elsevier

ER -

Tambuwala MM. Nanoemulsions as Effective Carriers for the treatment of Lung Cancer. In Kesharwani P, editor, Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer. 1 ed. Elsevier. 2019. p. 217